ABVC Biopharma Inc Share Price Today: Live Updates & Key Insights

ABVC Biopharma Inc share price today is $1.22, up -5.43%. The stock opened at $1.31 against the previous close of $1.29, with an intraday high of $1.33 and low of $1.19.

ABVC Biopharma Inc Share Price Chart

ABVC Biopharma Inc

us-stock
To Invest in {{usstockname}}
us-stock

ABVC Biopharma Inc Share Price Performance

$1.22 -0.0543(-5.43%) ABVC at 23 Mar 2026 11:51 AM Biotechnology
Lowest Today 1.19
Highest Today 1.33
Today’s Open 1.31
Prev. Close 1.29
52 Week High 5.48
52 Week Low 0.69
Day’s Range: Low 1.19 High 1.33
52-Week Range: Low 0.69 High 5.48
1 day return -
1 Week return -6.87
1 month return -13.47
3 month return -48.08
6 month return -57.19
1 year return +76.53
3 year return -80.81
5 year return -96.06
10 year return -

ABVC Biopharma Inc Institutional Holdings

Vanguard Group Inc 1.13

Geode Capital Management, LLC 0.80

Vanguard Institutional Extnd Mkt Idx Tr 0.75

Renaissance Technologies Corp 0.45

Fidelity Extended Market Index 0.42

State Street Corp 0.29

BlackRock Inc 0.22

Citadel Advisors Llc 0.22

Blackrock Extended Mkt Fund CF 0.22

Extended Equity Market Fund K 0.19

Fidelity Total Market Index 0.12

NT Ext Equity Mkt Idx Fd - L 0.11

Fidelity Series Total Market Index 0.10

Northern Trust Corp 0.10

XTX Topco Ltd 0.10

Spartan Extended Market Index Pool F 0.08

Northern Trust Extended Eq Market Idx 0.08

Spartan Total Market Index Pool G 0.06

Jane Street Group LLC 0.04

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.04

Fidelity Nasdaq Composite Index 0.02

Extended Equity Market Fund M 0.02

Dimensional US Core Equity 1 ETF 0.02

Dimensional US Sustainability Core 1 ETF 0.02

NT Ext Equity Mkt Idx Fd - NL 0.02

Tower Research Capital LLC 0.01

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.01

DFA US Core Equity 1 I 0.01

UBS Group AG 0.01

Northern Trust Wilshire 5000 0.01

SIMPLEX TRADING, LLC 0.00

NT US Market Cap Idx Fd - L 0.00

Bank of America Corp 0.00

Millennium Management LLC 0.00

Northwestern Mutual Wealth Management Co 0.00

SBI Securities Co Ltd 0.00

ABVC Biopharma Inc Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

ABVC Biopharma Inc Fundamentals

Market Cap 31.04 M

PB Ratio 2.8161

PE Ratio 0.0

Enterprise Value 34.02 M

Total Assets 21.06 M

Volume 77636

ABVC Biopharma Inc Company Financials

Annual Revenue FY23:739259 0.7M, FY22:969783 1.0M, FY21:355797 0.4M, FY20:483045 0.5M, FY19:701719 0.7M

Annual Profit FY23:311017 0.3M, FY22:683368 0.7M, FY21:350711 0.4M, FY20:464329 0.5M, FY19:681582 0.7M

Annual Net worth FY23:-12268660 -12.3M, FY22:-16312374 -16.3M, FY21:-12035851 -12.0M, FY20:-10593584 -10.6M, FY19:-3933240 -3.9M

Quarterly Revenue Q3/2025:795950 0.8M, Q2/2025:0 0.0M, Q1/2025:1966 0.0M, Q3/2024:389276 0.4M, Q2/2024:117142 0.1M

Quarterly Profit Q3/2025:795950 0.8M, Q2/2025:-80832 -0.1M, Q1/2025:1966 0.0M, Q3/2024:388980 0.4M, Q2/2024:116952 0.1M

Quarterly Net worth Q3/2025:-1246513 -1.2M, Q2/2025:-2257022 -2.3M, Q1/2025:-842075 -0.8M, Q3/2024:-186561 -0.2M, Q2/2024:-1012645 -1.0M

About ABVC Biopharma Inc & investment objective

Company Information ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-2001, an intraocular irrigation solution; ABV-2002, a corneal Storage Solution; and ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. The company has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California.

Organisation Biotechnology

Employees 16

Industry Biotechnology

CEO Dr. Uttam Yashwant Patil Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

ABVC Biopharma Inc FAQs

What is the share price of ABVC Biopharma Inc today?

The current share price of ABVC Biopharma Inc is $1.22.

Can I buy ABVC Biopharma Inc shares in India?

Yes, Indian investors can buy ABVC Biopharma Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy ABVC Biopharma Inc shares in India?

You can easily invest in ABVC Biopharma Inc shares from India by:

Can I buy fractional shares of ABVC Biopharma Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ABVC Biopharma Inc?

ABVC Biopharma Inc has a market cap of $31.04 M.

In which sector does ABVC Biopharma Inc belong?

ABVC Biopharma Inc operates in the Biotechnology sector.

What documents are required to invest in ABVC Biopharma Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of ABVC Biopharma Inc?

The PE ratio of ABVC Biopharma Inc is N/A and the PB ratio is 2.82.